Temoporfin (Foscan®, 5,10,15,20-tetra(m-hydroxyphenyl)chlorin)--a second-generation photosensitizer.
about
Drug Carrier for Photodynamic Cancer TherapyPhotodynamic nanomedicine in the treatment of solid tumors: perspectives and challengesHigh content screening as high quality assay for biological evaluation of photosensitizers in vitroMassive release of extracellular vesicles from cancer cells after photodynamic treatment or chemotherapyAnticancer activity of cationic porphyrins in melanoma tumour-bearing mice and mechanistic in vitro studies.Involvement of the mitochondria-caspase pathway in HeLa cell death induced by 2-ethanolamino-2-demethoxy-17-ethanolimino-hypocrellin B (EAHB)-mediated photodynamic therapy.Synthesis and biological evaluation of a library of glycoporphyrin compounds.Electrochemical, spectroscopic, and (1)O2 sensitization characteristics of 10,10-dimethylbiladiene complexes of zinc and copper.Synthesis and photophysical properties of chlorins bearing 0-4 distinct meso-substituents.Localization of liposomal mTHPC formulations within normal epithelium, dysplastic tissue, and carcinoma of oral epithelium in the 4NQO-carcinogenesis rat model.A palladium label to monitor nanoparticle-assisted drug delivery of a photosensitizer into tumor spheroids by elemental bioimaging.Photosensitizing effectiveness of a novel chlorin-based photosensitizer for photodynamic therapy in vitro and in vivo.Apoptosis of HeLa cells induced by a new targeting photosensitizer-based PDT via a mitochondrial pathway and ER stress.Combinatorial screening for specific drug solubilizers with switchable release profiles.Targeted photodynamic therapy in head and neck squamous cell carcinoma: heading into the future.Lead Structures for Applications in Photodynamic Therapy. 6. Temoporfin Anti-Inflammatory Conjugates to Target the Tumor Microenvironment for In Vitro PDT.mTHPC mediated, systemic photodynamic therapy (PDT) for nonmelanoma skin cancers: Case and literature review.Assessing of integration of ionizing radiation with Radachlorin-PDT on MCF-7 breast cancer cell treatment.New photosensitizers for photodynamic therapyBODIPY dyes in photodynamic therapy.A cell-targeted photodynamic nanomedicine strategy for head and neck cancers.Photodynamic therapy with conventional and PEGylated liposomal formulations of mTHPC (temoporfin): comparison of treatment efficacy and distribution characteristics in vivoPhotophysics of glycosylated derivatives of a chlorin, isobacteriochlorin and bacteriochlorin for photodynamic theragnostics: discovery of a two-photon-absorbing photosensitizer.Glycol porphyrin derivatives and temoporfin elicit resistance to photodynamic therapy by different mechanisms.The translocator protein as a potential molecular target for improved treatment efficacy in photodynamic therapy.Glycosylated Porphyrins, Phthalocyanines, and Other Porphyrinoids for Diagnostics and Therapeutics.Pro-oxidant and Antioxidant Effects in Photodynamic Therapy: Cells Recognise that Not All Exogenous ROS Are Alike.A Chlorin-Based Nanoscale Metal-Organic Framework for Photodynamic Therapy of Colon Cancers.Pdots, a new type of nanoparticle, bind to mTHPC via their lipid modified surface and exhibit very high FRET efficiency between the core and the sensitizer.A multifunctional bichromophoric nanoaggregate for fluorescence imaging and simultaneous photogeneration of RNOS and ROS.mTHPC-mediated photodynamic therapy of early stage oral squamous cell carcinoma: a comparison to surgical treatment.Smart Nanostructures for Cargo Delivery: Uncaging and Activating by Light.Photoinduced effects of m-tetrahydroxyphenylchlorin loaded lipid nanoemulsions on multicellular tumor spheroids.Transfer of a lipophilic drug (temoporfin) between small unilamellar liposomes and human plasma proteins: influence of membrane composition on vesicle integrity and release characteristics.Photodynamic therapy for hilar bile duct cancer: clinical evidence for improved tumoricidal tissue penetration by temoporfin.Photodynamic killing of Enterococcus faecalis in dentinal tubules using mTHPC incorporated in liposomes and invasomes.Pharmacokinetic and biodistribution study following systemic administration of Fospeg®--a Pegylated liposomal mTHPC formulation in a murine model.A Highly Efficient Chemiluminescence Probe for the Detection of Singlet Oxygen in Living Cells.Effect of mTHPC-mediated photodynamic therapy on 5-fluorouracil resistant human colorectal cancer cells.Quantitative In Vitro Assessment of Liposome Stability and Drug Transfer Employing Asymmetrical Flow Field-Flow Fractionation (AF4).
P2860
Q26782780-8E8E95AE-789C-4FAC-A7AC-3BD0645CD99DQ26827820-7D8AD544-DF46-43A3-A7F8-71A09CA69A64Q28534928-500BD54D-46B1-41FC-9B4F-53F2B078FD72Q30823413-B5265B8F-34D5-47C2-9375-396FADE84B00Q33615428-D56EE0CB-4850-4050-808C-4BCEA350BDEBQ34420750-E7B2350C-8F99-4EAB-981A-FE9634A77C81Q34423462-A7A436CC-CAD5-4FEF-8B3D-E1A689DB8926Q34525182-C60EFE23-63E7-44DB-AE9F-71BDC886E1CAQ34993906-4BA05450-6847-46A0-969F-77A0095A3355Q35029303-98C9991D-241A-45F8-B073-13D4DCA9A51AQ35059952-06E4CA90-9EDE-4978-BDAF-3B38A5847640Q35174573-B8B55E15-C30B-484B-A453-29CD7D3A4E3EQ35410329-012EC536-6485-4058-9CA9-BB82836FCB97Q35537690-CEA69BC0-5791-4E7C-933F-A102CFD0239FQ35538953-5053D7B4-3E89-48D3-B209-E7B1D225969AQ35636119-2BFE8694-ED3C-45F1-852F-5DEDAD1EEB17Q35805252-AE4EB8F3-F1D1-4462-BC0C-60DB1B097DDCQ35874411-C9934F90-82EA-4858-9A1F-F54CDADE4E9DQ35919257-548935BE-BE25-4484-8C5A-16E01837937CQ36445896-1107CF6B-7A8B-48D3-991E-0F6970A9D610Q37190425-9B52EFFF-31C6-4A9E-9460-DCBCD8FB19EBQ37231221-2578F416-A5E9-4C57-9773-3010AED3CE46Q37646852-AB729FA1-2D8A-41AB-AA4B-DA15E971DA68Q37704800-1943748F-2D0B-4791-AAEC-B08DAB8D137BQ38221277-BD604D5F-40A9-4897-8ACE-B94022E4F5A5Q38575844-0C7FDCCB-FC38-47F3-83C2-8A4482E8097EQ38792932-FB1B2E9D-20A3-4823-981C-37CB83EACD2CQ38864805-82648042-A3D6-44D0-8599-77A6E8E30291Q39020425-FF3B4743-5BEC-4D3F-A611-CDC5A797487EQ39136992-70652992-ECC3-4B2C-84FF-FC90665A5DD0Q39416520-630E8E8A-132B-4334-9AF2-C3F7FB4ED8BFQ40334818-A517F681-8954-4CE1-B2C5-7100F7492B8CQ41040026-A37D5E03-31C7-4248-9384-4495F24431C2Q41611137-4C2C7027-2592-4871-AE0B-5EB0CB6EFF16Q42267989-5B5D0579-AB3D-406F-B843-0FEEFAFB2C0BQ44199970-536548E7-E39A-4072-A4A5-AE67B4EFA6D0Q45807605-A1B5793A-F297-495F-919D-3301A4AC6EB0Q46330036-29F757D7-34B6-4DCE-8855-AED923E0EA50Q46365124-154F818C-ACA5-4F82-B1B3-75979F338FDDQ46635086-8A618F51-ABA2-4DF6-90EA-A0D756E7FB2A
P2860
Temoporfin (Foscan®, 5,10,15,20-tetra(m-hydroxyphenyl)chlorin)--a second-generation photosensitizer.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Temoporfin (Foscan®, 5,10,15,2 ...... nd-generation photosensitizer.
@en
Temoporfin (Foscan®, 5,10,15,2 ...... nd-generation photosensitizer.
@nl
type
label
Temoporfin (Foscan®, 5,10,15,2 ...... nd-generation photosensitizer.
@en
Temoporfin (Foscan®, 5,10,15,2 ...... nd-generation photosensitizer.
@nl
prefLabel
Temoporfin (Foscan®, 5,10,15,2 ...... nd-generation photosensitizer.
@en
Temoporfin (Foscan®, 5,10,15,2 ...... nd-generation photosensitizer.
@nl
P2860
P1476
Temoporfin (Foscan®, 5,10,15,2 ...... ond-generation photosensitizer
@en
P2093
Johan C Brandt
P2860
P304
P356
10.1111/J.1751-1097.2011.00986.X
P577
2011-09-19T00:00:00Z